We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Opexa Therapeutics Announces TcelnaTM as New Brand Name for MS Therapy

Product News   May 22, 2012

 
Opexa Therapeutics Announces TcelnaTM as New Brand Name for MS Therapy
FURTHER INFORMATION
 
 
 

Related Product News

Additional Funding Awarded for Regenerative Cartilage Therapy Development

Product News

Mogrify has announced that it has secured $1.1M of additional funding from SBRI Healthcare to assess its regenerative cartilage therapy.

READ MORE

Avacta and Daewoong Pharmaceutical Form Immunotherapy Focused Joint Venture

Product News

Avacta and Daewoong Pharmaceutical have announced a collaboration to develop the next generation of cell and gene therapies incorporating Affimer proteins to enhance the immune-modulatory effects.

READ MORE

Expedeon Approves Future Focus on DNA Manufacturing For Gene Therapy

Product News

Expedeon shareholders have approved the sale of its proteomics and immunology business, as well as the proposed name change to 4basebio AG, reflecting the Company’s future focus on DNA manufacturing for gene therapy and gene vaccines.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE